Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Although elevated activity of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) has been proposed to mediate comorbid depression in inflammatory disorders, its causative role has never been tested. We report that peripheral administration of lipopolysaccharide (LPS) activates IDO and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests. Blockade of IDO activation either indirectly with the anti-inflammatory tetracycline derivative minocycline, that attenuates LPS-induced expression of proinflammatory cytokines, or directly with the IDO antagonist 1-methyltryptophan (1-MT), prevents development of depressive-like behavior. Both minocycline and 1-MT normalize the kynurenine/tryptophan ratio in the plasma and brain of LPS-treated mice without changing the LPS-induced increase in turnover of brain serotonin. Administration of L-kynurenine, a metabolite of tryptophan that is generated by IDO, to naive mice dose dependently induces depressive-like behavior. These results implicate IDO as a critical molecular mediator of inflammation-induced depressive-like behavior, probably through the catabolism of tryptophan along the kynurenine pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“depressive-like behaviors in rodents are mediated by an enzyme that degrades tryptophan, called indoleamine 2,3dioxygenase (IDO; O'Connor et al., 2009; see also Maes et al., 2011)”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as O'Connor et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal studies have shown that inflammation promotes a pattern of behavior known as sickness behavior that includes symptoms of depression, such as fatigue, anhedonia, and social withdrawal.[10,11]”
From SUICIDAL IDEATION IS ASSOCIATED WITH ELEVATED INFLAMMATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: Research Article: Suicidal Ideation and Inflammation (2013) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, blocking glutamate receptors with ketamine or inhibiting IDO activity protects mice from LPS- or stress-induced depressive-like behaviour but leaves the inflammatory response intact85,86.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“In preclinical models, LPS-induced depressive behavior is mediated by IDO activation (O’Connor et al., 2009).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as O’Connor et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Self-citationPrevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,067
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999
Self-citation
Cited by
Items 601–700 of 1,001
Zhao, Y., Zhang, Y., & Pan, F. (2015) · Central European Journal of Immunology · doi:10.5114/ceji.2015.49427 · Cited by 34
Association between increased tryptophan degradation and depression in cancer patients
Kurz, K., Schroecksnadel, S., Weiss, G., & Fuchs, D. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328340d849 · Cited by 36
Jiang, C., Zhou, T. G., Chen, W., Lin, D., Guo, A., Liu, Z., & Fei, E. (2020) · Biology · doi:10.3390/biology9110359 · Cited by 34
Rahman, S. U., Ali, T., Hao, Q., He, K., Li, W., Ullah, N., Zhang, Z., Jiang, Y., & Li, S. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03396-w · Cited by 33
RetractedDu, R.-W., Du, R., & Bu, W.-G. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9556-y · Cited by 36
Kynurenines and Vitamin B6: Link Between Diabetes and Depression.
Oxenkrug, G. F., Ratner, R., & Summergrad, P. (2013) · Journal of Bioinformatics and Diabetes · doi:10.14302/issn.2374-9431.jbd-13-218 · Cited by 34
Jiang, X., Lin, Q., Xu, L., Chen, Z., Yan, Q., Chen, L., & Yu, X. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00011 · Cited by 35
Personalized Medicine Using Neuroimmunological Biomarkers in Depressive Disorders
Chi, S., & Lee, M. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020114 · Cited by 33
“Moreover, kynurenine was associated with depression-like symptoms in animal models, and the blockade of the enzyme inhibited depressive-like behavior in mice [34].”
BackgroundMiura, H., Ando, Y., Noda, Y., Isobe, K., & Ozaki, N. (2011) · Stress · doi:10.3109/10253890.2010.541539 · Cited by 34
“2008a) as well as systemic administration of lipopolysaccharide (LPS; Kita et al. 2002; Miura et al. 2009, 2010; O’Connor et al. 2009) have been shown to increase brain KYN levels and shift the balance between KYN and 5-HT pathways to the KYN pathway.”
BackgroundMartin, S. A., Dantzer, R., Kelley, K. W., & Woods, J. A. (2013) · NeuroImmunoModulation · doi:10.1159/000356144 · Cited by 37
Self-citationGuo, Y., Cai, H., Chen, L., Liang, D., Yang, R., Dang, R., & Jiang, P. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.04.006 · Cited by 33
“Interestingly, administration of KYN alone also successfully induces the rats to a depression-like state (O'Connor et al., 2009).”
BackgroundBerkiks, I., Boulbaroud, S., García‐Segura, L. M., Mesfioui, A., Ouichou, A., Mouden, S., Benmhammed, H., hasnaoui, A. E., Nakache, R., Bahbiti, Y., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.125 · Cited by 36
Duda, W., Curzytek, K., Kubera, M., Connor, T. J., Fagan, E. M., Basta‐Kaim, A., Trojan, E., Papp, M., Gruca, P., Budziszewska, B., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.039 · Cited by 34
Khedr, L. H., Nassar, N. N., Rashed, L. A., El-denshary, E. D., & Abdel-Tawab, A. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116869 · Cited by 32
Alam, M. M., Zameer, S., Najmi, A. K., Ahmad, F. J., Imam, S. S., & Akhtar, M. (2020) · Drug Research · doi:10.1055/a-1131-7793 · Cited by 34
Lara-Espinosa, J. V., Santana-Martínez, R. A., Maldonado, P. D., Zetter, M. A., Becerril‐Villanueva, E., Pérez‐Sánchez, G., Pavón, L., Mata‐Espinosa, D., Barrios‐Payán, J., López-Torres, M. O., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249483 · Cited by 34
“Furthermore, there are previous findings that suggest that acute and chronic inflammatory reactions such as obesity, chronic liver disease, inflammatory bowel disease, systemic administration of the Bacillus Calmette–Guerin (BCG) [16], infection with M. lepraemurium [17] and lipopolysaccharide (LPS) administration ind…”
BackgroundInfluentialNettis, M. A. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100335 · Cited by 37
“For example, minocycline proved to block the release of cytokines and the activation of the KYN pathway in the CNS after LPS administration in mice (O’Connor et al., 2009).”
Sushma, G., Vaidya, B., Sharma, S., Devabattula, G., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109480 · Cited by 34
Genetic biomarkers of depression
Tamatam, A., Bawa, A. S., & Khanum, F. (2012) · Indian journal of human genetics · doi:10.4103/0971-6866.96639 · Cited by 35
“[131] In addition, based on the differential expression of relevant metabolic enzymes, KYN is preferentially converted to kynurenic acid (KA) in astrocytes and quinolinic acid (QUIN) in microglia.”
Anti-Inflammatory Drugs in Psychiatry
Berthold-Losleben, M., Heitmann, S., & Himmerich, H. (2009) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152809789352221 · Cited by 32
Methyl jasmonate attenuated lipopolysaccharide-induced depressive-like behaviour in mice
Adebesin, A., Adeoluwa, O. A., Eduviere, A. T., & Umukoro, S. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.06.007 · Cited by 32
“Moreover, proinflammatory cytokines including IL-6 and IL-1b were elevated in the plasma or cerebrospinal fluid of depressed patients (O'Connor et al., 2009; Capuron and Dantzer, 2003) and these heightened levels of cytokines were associated with the severity of the disease (Yirmiya, 1996; O'Connor…”
InfluentialMicheli, L., Spitoni, S., Mannelli, L. D. C., Bilia, A. R., Ghelardini, C., & Pallanti, S. (2020) · Phytotherapy Research · doi:10.1002/ptr.6684 · Cited by 35
“Behavioral studies in rodents have shown that systemic LPS injection, by a potent activation of the immune response, induces a sickness response, characterized by social withdrawal, fatigue, anorexia, and alterations in sleep patterns and cognition, followed by a behavior similar to clinically relevant symptoms of dep…”
BackgroundWu, Z., Zhou, L., Sun, L., Xie, Y., Xiao, L., Wang, H., & Wang, G. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.03.016 · Cited by 33
Cardinal, P., de Oliveira, C. M., Sauvant, J., Foury, A., Darnaudéry, M., Vancassel, S., Castanon, N., & Capuron, L. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02330-9 · Cited by 33
Self-citationEneni, A.-E. O., Ben‐Azu, B., Ajayi, A. M., & Aderibigbe, A. O. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02077-9 · Cited by 32
Brain FNDC5/Irisin Expression in Patients and Mouse Models of Major Depression
Lima‐Filho, R. A. S., Fortuna, J. T. S., Cozachenco, D., Isaac, A. R., Silva, N. M. L. E., Saldanha, A., Santos, L. E., Ferreira, S. T., Lourenco, M. V., & Felice, F. G. D. (2023) · eNeuro · doi:10.1523/eneuro.0256-22.2023 · Cited by 34
“LPS and corticosterone are thought to induce depressive-like states through different mechanisms and lead to different behavioral outcomes (Gourley et al., 2008; O’Connor et al., 2009).”
BackgroundMethodKumar, V., Rudra, A., Sreedhara, M. V., Subramani, T. S., Prasad, D. S., Das, M. L., Murugesan, S. V., Yadav, R., Trivedi, R. K., Louis, J. V., et al. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.205 · Cited by 31
Gałecki, P., Gałecka, E., Maes, M. H. J., Orzechowska, A., Berent, D., Talarowska, M. E., Bobińska, K., Lewiñski, A., Bieńkiewicz, M., & Szemraj, J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.011 · Cited by 31
Lipocalin-2 is dispensable in inflammation-induced sickness and depression-like behavior
Vichaya, E. G., Gross, P. S., Estrada, D. J., Cole, S. W., Grossberg, A. J., Evans, S. E., Tuvim, M. J., Dickey, B. F., & Dantzer, R. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05190-7 · Cited by 34
Self-citationImbeault, S., Goiny, M., Liu, X., & Erhardt, S. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.44 · Cited by 34
“, 2013), which, in turn, increases expression of indoleamine 2,3 dioxygenase (IDO1) (O’Connor et al., 2009), the rate-limiting enzyme of the kynurenine pathway that converts L-tryptophan into N-formylkynurenine (Shimizu et al.”
BackgroundMethodResultInfluentialMicroglial circ-UBE2K exacerbates depression by regulating parental gene UBE2K via targeting HNRNPU
Cai, Y., Ji, Y., Liu, Y., Zhang, D., Gong, Z., Li, L., Chen, X., Liang, C., Feng, S., Lu, J., et al. (2024) · Theranostics · doi:10.7150/thno.96890 · Cited by 33
Zhang, A. Y., Elias, E., & Manners, M. T. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106610 · Cited by 32
Yao, W., Zhang, J., Ishima, T., Ren, Q., Yang, C., Dong, C., Ma, M., Saito, A., Honda, T., & Hashimoto, K. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.037 · Cited by 31
Berkiks, I., Garcia-Segura, L. M., Nassiri, A., Mesfioui, A., Ouichou, A., Boulbaroud, S., Bahbiti, Y., Lopez-Rodriguez, A. B., Hasnaoui, E., & El Hessni, A. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.11.037 · Cited by 30
Shi, B., Luo, J., Yang, F. Y., Liu, X., Rao, Z., Liu, R., & Zeng, N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01324 · Cited by 33
Luduvico, K. P., Spohr, L., Soares, M. S. P., Teixeira, F. C., de Farias, A. S., Bona, N. P., Pedra, N. S., Félix, A. D. O. C., Spanevello, R. M., & Stefanello, F. M. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03064-5 · Cited by 33
Stress and signaling pathways regulating autophagy: From behavioral models to psychiatric disorders
Pierone, B. C., Pereira, C. A., Garcez, M. L., & Kaster, M. P. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113485 · Cited by 33
Dantas, R. L., Freff, J., Ambrée, O., Beins, E. C., Forstner, A. J., Dannlowski, U., Baune, B. T., Scheu, S., & Alferink, J. (2021) · Cells · doi:10.3390/cells10040941 · Cited by 32
“More specifically, LPS-binding to TLR4 activates a complex signaling pathway dependent on the adaptor molecules MyD88 and TRIF leading to translocation of NF-κB and IRF3 into the nucleus for transcription of inflammatory genes and type I IFN [55,77].”
BackgroundInfluentialPeng, Z., Li, X., Li, J., Dong, Y., Gao, Y., Liao, Y., Yan, M., Yuan, Z., & Cheng, J. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00765-x · Cited by 31
Chen, S., Chen, F., Amin, N., Ren, Q., Ye, S., Hu, Z., Tan, X., Jiang, M., & Fang, M. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.09.013 · Cited by 31
Lü, C., Wei, Z., Wang, Y., Li, S., Tong, L., Liu, X., Fan, B., & Wang, F. (2022) · Food & Function · doi:10.1039/d2fo01437h · Cited by 35
Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMC
Gostner, J. M., Ganzera, M., Becker, K., Geisler, S., Schroecksnadel, S., Überall, F., Schennach, H., & Fuchs, D. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-503 · Cited by 31
“The most prominent IDO inhibitor1-methyl tryptophan (1-MT) has been shown to counteract microbial-induced depressive-like symptoms in animal studies [40].”
BackgroundDeWitt, S. J., Bradley, K., Lin, N., Yu, C., & Gabbay, V. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.040 · Cited by 32
Dostal, C. R., Gamsby, N. S., Lawson, M. A., & McCusker, R. H. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.12.006 · Cited by 33
Self-citationAnhedonic-like behavior correlates with IFNγ serum levels in a two-hit model of depression
Géa, L. P., Colombo, R., da Rosa, E. D., Antqueviezc, B., de Aguiar, É. Z., Hizo, G. H., Schmidt, G. B., de Oliveira, L. F., Stein, D. J., & Rosa, A. R. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112076 · Cited by 36
Krishna, S., Dodd, C. A., & Filipov, N. M. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.038 · Cited by 32
“which can persist even after the immediate behavioral response (reduction in locomotor activity) to LPS administration has normalized [16, 21, 22].”
BackgroundAlboni, S., Benatti, C., Colliva, C., Radighieri, G., Blom, J. M. C., Brunello, N., & Tascedda, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.603979 · Cited by 32
Rengasamy, M. L., Marsland, A. L., Spada, M. L., Hsiung, K. S., Kovats, T., & Price, R. B. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100177 · Cited by 32
“…urine, CSF, or brain tissue) in depressed patients compared to healthy controls, although antidepressant-free depressed patients had elevated QA levels compared to controls and blood levels of QA were elevated in depressed patients compared to controls(O’connor et al., 2009; Ogyu et al., 2018).”
Feng, X., Hu, H.-D., Chen, J., Long, C., Yang, L., & Wang, L. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.08.216 · Cited by 30
Zhang, Y., Li, Y., Chen, X., Chen, X., Chen, C., Wang, L., Xu, D., Wang, G., Gu, R., Li, F. Y., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00677 · Cited by 30
Li, S., Zhu, Z., Lan, T., Wu, Y., Li, Y., Wang, C., Jian, W., & Yu, S. Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110595 · Cited by 30
Bhusal, A., Kim, J., Kim, S.-C., Hwang, E. M., Ryu, H., Ali, M. S., Park, S., Lee, W., & Suk, K. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113813 · Cited by 32
Minocycline effect on life and health span of Drosophila melanogaster.
Oxenkrug, G. F., Navrotskaya, V., Vorobyova, L., & D, P. S. M. (2012) · Europe PMC (PubMed Central) · Cited by 33
Mansour, A., Mohamed, B. M. S. A., Aboul‐Fotouh, S., Ibrahim, E. A.-S., Shehata, H., Yassin, N., El‐Eraky, W. I., & Abdel-Tawab, A. M. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s41020 · Cited by 37
“10 Recently, O’Connor et al 11 reported that peripheral administration of lipopolysaccharide (LPS) activates IDO and culminates in a distinct depressive-like behavioral syndrome.”
BackgroundInfluentialSiebler, P. H., Heinze, J. D., Kienzle, D. M., Hale, M. W., Lukkes, J. L., Donner, N. C., Kopelman, J. M., Rodriguez, O. A., & Lowry, C. A. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0564-3 · Cited by 33
Wu, Y. H., Wei, Z., Li, Y., Wei, C., Li, Y., Cheng, P., Xu, H., Li, Z., Guo, R. H., Qi, X., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01359 · Cited by 34
Teixeira, L. D., Kling, D. N., Lorca, G. L., & González, C. F. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0120 · Cited by 28
Zhang, S., Zong, Y., Ren, Z., Hu, J., Wu, X., Xiao, H., Qin, S., Zhou, G., Ma, Y., Zhang, Y., et al. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15016 · Cited by 29
Inflammation increases the development of depression behaviors in male rats after spinal cord injury
Brakel, K., Aceves, M., Garza, A., Yoo, C., Escobedo, G., Panchani, N., Shapiro, L. A., & Hook, M. A. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100258 · Cited by 31
Brain derived neurotrophic factor deficiency exacerbates inflammation-induced anhedonia in mice
Parrott, J. M., Porter, G. A., Redus, L., & O’Connor, J. C. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105404 · Cited by 29
Self-citationFenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule
Potenza, R. L., Lodeserto, P., & Orienti, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137426 · Cited by 31
“LPS administration is widely used to induce depressive-like behavior in rodents as LPS-treated mice mimic human depressive symptoms with an earlier “sickness behavior” phase which includes fever, anorexia, reduction of locomotion and a decrease in social interaction, followed by several depressive-like behaviors [90].”
MethodPathophysiology of Depression: Stingless Bee Honey Promising as an Antidepressant
Zakaria, F. H., Ismail, S., Mustafa, M. Z., & Shafin, N. (2022) · Molecules · doi:10.3390/molecules27165091 · Cited by 33
“This has been proven in animal models and drug therapy patients with interferon-α [81,82].”
ResultZielińska, D., Karbowiak, M., & Brzezicka, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191711022 · Cited by 31
“Even small amounts of LPS can stimulate proinflammatory cytokine secretion and increase IDO activity and norepinephrine in plasma, which relates to depression symptoms [36].”
BackgroundVanderZwaag, J., Halvorson, T., Dolhan, K., Šimončičová, E., Ben‐Azu, B., & Tremblay, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03772-0 · Cited by 30
Kim, E., Figueiredo, I., Simmons, C., Randall, K., Gonzalez, L. R., Wood, T., Ranieri, B., Sureda-Gibert, P., Howes, O. D., Pariante, C. M., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.010 · Cited by 30
Guan, X., Lin, W., & Tang, M. (2015) · PsyCh Journal · doi:10.1002/pchj.87 · Cited by 31
Sex Differences in ICR Mice in the Morris Water Maze Task
GE, J.-F., QI, C.-C., QIAO, J.-P., WANG, C.-W., & Zhou, J. (2013) · Physiological Research · doi:10.33549/physiolres.932371 · Cited by 28
“ICR mice are commonly employed in neuroscience, immunology, and pharmacology studies because of good reproductive performance and a fast growth rate (O'Connor et al. 2009, Zhong et al. 2009).”
Mitigation of heat stress-related complications by a yeast fermentate product
Ducray, H. A. G., Globa, L. P., Pustovyy, O. M., Reeves, S., Robinson, L. E., Vodyanoy, V. J., & Sorokulova, I. B. (2016) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2016.06.002 · Cited by 28
Fox, H. C., Milivojevic, V., Angarita, G. A., Stowe, R., & Sinha, R. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117691455 · Cited by 29
“Pathological activation of inflammatory mediators has been associated with similar deleterious mood symptoms in chronically ill patients (Maes et al., 2009; McNally et al., 2008; O’Connor et al., 2009), and the treatment of both patients (Dunn et al.”
BackgroundThe antidepressant-like effect of trans-astaxanthin involves the serotonergic system
Jiang, X., Zhu, K., Quan-yi, X., Wang, G., Zhang, J., Cao, R., Jiang, Y., & Yu, X. (2017) · Oncotarget · doi:10.18632/oncotarget.16069 · Cited by 30
“The importance of the activation of IDO in the pathophysiology of depression is also supported by the evidence that the blockade of IDO inhibits the onset of the lipopolysaccharide-induced depressive-like behavior in mice [31].”
Albrecht, M. A., Vaughn, C. N., Erickson, M. A., Clark, S. M., & Tonelli, L. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206985 · Cited by 30
Endocannabinoid modulation of inflammatory hyperalgesia in the IFN-α mouse model of depression
Fitzgibbon, M., Kerr, D. M., Henry, R. J., Finn, D. P., & Roche, M. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.09.006 · Cited by 30
Zhong, X., Cao, W., Zhao, H., Chen, L., Cao, J., Wei, L., Tang, Y., Zhong, J., Xiao, X., Zu, X., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.11.001 · Cited by 28
“For example, lipopolysaccharide (LPS) treatment leads to depressive behaviors accompanied by an increased production of pro-inflammatory cytokines in mice (O'Connor et al. 2009a).”
BackgroundMethodInfluentialVeit, C., Janczak, A. M., Ranheim, B., Vas, J., Valros, A., Sandercock, D. A., Piepponen, P. T., Dulgheriu, D., & Nordgreen, J. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.617634 · Cited by 31
“In rodents 79 it has been shown that a blockade of IDO activity prevents the development of depressive-like 80 behavior, whereas administration of KYN induces depressive-like behavior (10).”
BackgroundInfluentialZhang, K., Lei, N., Li, M., Li, J., Caijun, L., Shen, Y. L., Guo, P., Xiong, L., & Xie, Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.791991 · Cited by 29
“Depression-like behavior can be induced by IDO activation in animals, and application of IDO inhibitors can alleviate depressive state of mice (16, 17).”
BackgroundSouza, L. C., Jessé, C. R., de Gomes, M. G., Fabbro, L. D., Goes, A. T. R., Donato, F., & Boeira, S. P. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2329-2 · Cited by 28
“[27], showing that 1-MT intervention blocked depressive-like behavior, but had no effect on 5-HT turnover in CD-1 mice at 24 h after LPS injection.”
BackgroundResultInfluentialIndoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer’s Disease and Geriatric Depression
Savonije, K., Meek, A. R., & Weaver, D. F. (2023) · Brain Sciences · doi:10.3390/brainsci13060852 · Cited by 31
Protective mechanism of Paeonol on central nervous system
Wu, R., Liu, Y., Zhang, F., Dai, S., Xue, X., Peng, C., Li, Y., & Li, Y. (2023) · Phytotherapy Research · doi:10.1002/ptr.8049 · Cited by 29
Engler-Chiurazzi, E. B. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1360242 · Cited by 32
Liang, W., Liu, Y., Zhou, K., Jian, P., Zhang, Q., Chang, Z., Wu, L., Hong-sheng, C., & Zhang, L. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114655 · Cited by 27
Karczewski, J., Zielińska, A., Staszewski, R., Eder, P., Dobrowolska, A., & Souto, E. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116145 · Cited by 26
Boktor, J. C., Adame, M. D., Rose, D. R., Schumann, C. M., Murray, K. D., Bauman, M. D., Careaga, M., Mazmanian, S. K., Ashwood, P., & Needham, B. D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01752-y · Cited by 48
Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments
Suseelan, S., & Pinna, G. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.09.001 · Cited by 33
Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases
Shen, H., Xu, X., Bai, Y., Wang, X., Wu, Y., Zhong, J., Wu, Q., Luo, Y., Shang, T., Shen, R., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115258 · Cited by 27
Souza, L. C., Jessé, C. R., de Gomes, M. G., Viana, C. E., Mattos, E., Silva, N. C., & Boeira, S. P. (2017) · Neurotoxicity Research · doi:10.1007/s12640-016-9691-8 · Cited by 28
“It is well-known that minocycline blocks macrophage and microglial activation in various in vivo animal models of peripheral or brain inflammation (O’Connor et al. 2009).”
BackgroundResultZhang, Y., Fan, K., Liu, Y., Liu, G., Yang, X., & Ma, J. (2018) · Neurochemical Research · doi:10.1007/s11064-017-2320-y · Cited by 28
“It has been demonstrated in other studies that some inflammatory cytokines can upregulate the expression and activity of central indoleamine 2,3-dioxygenase (IDO), an initial and rate limiting extrahepatic enzyme of kynurenine pathway, contributing to inflammation-associated depression-like behaviour [49, 50].”
Wu, Y. H., Li, Y., Jia, Y., Wei, C., Xu, H., Guo, R. H., Li, Y., Jia, J., Qi, X., & Gao, X. (2017) · Molecular BioSystems · doi:10.1039/c7mb00494j · Cited by 29
Ignácio, Z. M., Calixto, A. V., da Silva, R. H., Quevedo, J., & Réus, G. Z. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.12.012 · Cited by 30
“It is also important to consider that minocycline, a drug that inhibits microglial function also exerted an antidepressant-like effect in animal models of depression (O'Connor et al., 2009) and prevented suppression of hippocampal neurogenesis (Zheng et al., 2015).”
Souza, L. C., Jessé, C. R., Fabbro, L. D., de Gomes, M. G., Gomes, N. S., Filho, C. B., Goes, A. T. R., Wilhelm, E. A., Luchese, C., Roman, S. S., et al. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.01.005 · Cited by 29
“Moreover, increased IDO enzyme activity and elevated levels of KYN have been associated with inflammation-associated depression and anxiety (Gibney et al., 2013; O'Connor et al., 2009; Salazar et al., 2012).”
Maras, P. M., Hebda-Bauer, E. K., Hagenauer, M. H., Hilde, K. L., Blandino, P., Watson, S. J., & Akil, H. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01821-4 · Cited by 26
“The clinical trials are supported by many rodent studies that report anti-depressant effects of minocycline (Henry et al., 2008; Molina-Hernández et al., 2008; Pae et al., 2008; O’Connor et al., 2009; Arakawa et al., 2012; Hinwood et al., 2012, 2013; Zhu et al., 2014; Kreisel et al., 2014; Zheng et al., 2015; Majidi e…”
BackgroundInvolvement of FGF-2 modulation in the antidepressant-like effects of liquiritin in mice
Chen, M., Zhang, Q.-P., Zhu, J., Cheng, J., Liu, Q., Xu, G., Li, C., & Yi, L. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173297 · Cited by 26
Camargo, A., Dalmagro, A. P., Wolin, I. A. V., Kaster, M. P., & Rodrigues, A. L. S. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.09.057 · Cited by 26
Goodkin, K., Evering, T. H., Anderson, A. M. L., Ragin, A. B., Monaco, C. L., Gavegnano, C., Avery, R. J., Rourke, S. B., Cysique, L. A., & Brew, B. J. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1130938 · Cited by 27
Toward a better understanding of the central consequences of intestinal inflammation
Nyuyki, K. D., & Pittman, Q. J. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12935 · Cited by 28
van der Doef, T. F., Doorduin, J., van Berckel, B. N. M., & Červenka, S. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0140-0 · Cited by 27
“The bacterial endotoxin lipopolysaccharide (LPS) is often used to induce depressive-like behaviour in rodents, leading to immediate sickness behaviour followed by behavioural deficits that can be linked to depression [70, 71].”
BackgroundComparison of commonly used ICR stocks and the characterization of Korl:ICR
Shin, H., Cho, Y. M., Shin, H. J., Kim, H. D., Choi, K. M., Kim, M.-G., Shin, H. D., & Chung, M. W. (2017) · Laboratory Animal Research · doi:10.5625/lar.2017.33.1.8 · Cited by 26
Schlaak, J. F., Trippler, M., Hoyo-Becerra, C., Erim, Y., Kis, B., Wang, B., Scherbaum, N., & Gerken, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038668 · Cited by 25
Cao, M., Guo, Z., Wang, J., Ma, H.-Y., Zhong, S.-J., Hu, Y., Qin, X., & Lan, R. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.03.014 · Cited by 27
Zhang, Y., Chen, S., Tian, W., Zhu, H., Li, W., Dai, W., Zhang, X., Gu, X., & Su, D. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.817351 · Cited by 33
Zheng, Z.-H., Lin, X.-C., Lu, Y., Cao, S.-R., Liu, X.-K., Dong, L., Yang, F.-H., Zhang, Y.-B., Tu, J., Pan, B., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110208 · Cited by 28
Metadata
- Authors
- O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Dantzer, R
- Venue
- Molecular Psychiatry
- Published
- 2008-01-15
- Volume
- 14
- Issue
- 5
- Pages
- 511-522
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2683474
- OpenAlex
- W2050508296
- Cited by
- 1,278
- References
- 56
- Citations by year
- 2026: 45 · 2025: 68 · 2024: 82 · 2023: 86 · 2022: 94 · 2021: 106 · 2020: 88 · 2019: 86 · 2018: 95 · 2017: 87 · 2016: 88 · 2015: 76 · 2014: 61 · 2013: 71 · 2012: 38
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG029573)
- National Institute of Mental Health (R01MH079829, R01MH071349, R01 MH-71349)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK059802, T32 DK59802-01)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- indoleamine 2,3-dioxygenase, lipopolysaccharide, depression-like behavior, kynurenine pathway, tryptophan catabolism, minocycline, 1-methyltryptophan, L-kynurenine, kynurenine/tryptophan ratio, serotonin turnover, inflammatory cytokines, comorbid depression
- MeSH terms
- Animals, Behavior, Animal, Chromatography, High Pressure Liquid, Cytokinins, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Gene Expression Regulation, Kynurenine, Lipopolysaccharides, Male, Mice, Inbred ICR, Minocycline, Motor Activity, Swimming, Time Factors, Tryptophan, Hindlimb Suspension, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.